Members |
targetComponentId |
Entire shoulder girdle region |
Entire shoulder region |
Entire side of head |
Structure of half of head lateral to midsagittal plane (body structure) |
Entire single tooth surface |
Entire tooth surface (body structure) |
Entire sphincter vaginae |
Entire bulbospongiosus muscle |
Entire spinal nerve root C0 |
Entire spinal nerve root C1 (body structure) |
Entire splenius muscle of trunk |
Entire splenius cervicis muscle |
Entire striatostriatal fibers of internal capsule |
Entire thalamosensory cortical fibers of internal capsule |
Entire structure of tributary of lateral thoracic vein |
Entire tributary of axillary vein |
Entire synovial membrane of ankle |
Entire synovial membrane of ankle joint |
Entire synovial membrane of elbow |
Entire synovial membrane of elbow joint (body structure) |
Entire synovial membrane of hip |
Entire synovial membrane of hip joint (body structure) |
Entire synovial membrane of knee |
Entire synovial membrane of knee joint (body structure) |
Entire synovial membrane of lower limb |
Entire synovial membrane of joint of lower limb (body structure) |
Entire systemic venous pathway |
Systemic venous pathway |
Entire tendon or attachment of biceps brachii |
Entire tendon of biceps brachii |
Entire thenar and hypothenar spaces |
Structure of thenar and hypothenar spaces |
Entire three tooth surfaces |
Entire tooth surface (body structure) |
Entire transverse modiolar muscle |
Entire risorius muscle |
Entire tricuspid valve sub-part |
Entire tricuspid valve |
Entire two tooth surfaces |
Entire tooth surface (body structure) |
Entire undescended left testis |
Undescended left testicle |
Entire undescended right testis |
Undescended right testicle |
Entire undescended testis |
Undescended testicle |
Entire upper inner quadrant of female breast |
Entire upper inner quadrant of breast |
Entire upper inner quadrant of male breast |
Entire upper inner quadrant of breast |
Entire upper outer quadrant of female breast |
Entire upper outer quadrant of breast |
Entire upper outer quadrant of male breast |
Entire upper outer quadrant of breast |
Entire zygomatic tripod |
Entire zygomatic bone and bone of zygomatic arch (body structure) |
Entoloma |
Entoloma lividus |
Entomopoxvirus |
Subfamily Entomopoxvirinae (organism) |
Entomopoxvirus, Genus A |
Genus Alphaentomopoxvirus |
Entomopoxvirus, Genus B |
Genus Betaentomopoxvirus (organism) |
Entonox analgesia |
Nitrous oxide and oxygen gas analgesia (procedure) |
Entonox analgesia in labor |
Nitrous oxide and oxygen gas analgesia in labor (procedure) |
Entropion or trichiasis of eyelid NOS |
Entropion and trichiasis of eyelid |
Entsulfon |
Entsufon (substance) |
Enucleation of lesion of organ NOC |
A removal of an anatomic or pathologic structure in entirety without breakage |
Environmental risk assessment declined |
Environmental risk assessment declined (situation) |
Enzymes/specific proteins NOS |
Enzyme/specific protein level measurement |
Enzymes/specific proteins NOS |
Enzyme/specific protein level measurement |
Eosinophilic leukemia |
Chronic eosinophilic leukemia (morphologic abnormality) |
Ependymoma - category |
Ependymoma (morphologic abnormality) |
Ependymoma, no International Classification of Diseases for Oncology subtype |
Malignant ependymoma |
Eperythrozoon coccoides |
Mycoplasma coccoides (organism) |
Eperythrozoon ovis |
Mycoplasma ovis (organism) |
Eperythrozoon suis |
Mycoplasma haemosuis (organism) |
Eperythrozoon wenyonii |
Mycoplasma wenyonii (organism) |
Epicardial echocardiography |
Epicardial echocardiography (procedure) |
Epidermal and animal protein specific diagnostic allergen extract |
Animal material diagnostic allergen extract (product) |
Epidermolysis bullosa simplex with neuromuscular disease |
A form of epidermolysis bullosa simplex (EBS) characterized by generalized blistering associated with muscular dystrophy. |
Epididymogram |
Plain X-ray of epididymis with contrast (procedure) |
Epididymography |
Plain X-ray of epididymis with contrast (procedure) |
Epidural injection of neurolytic substance, caudal |
Epidural injection of neurolytic via caudal route |
Epidural injection of neurolytic substance, lumbar |
Epidural injection of neurolytic solution, lumbar |
Epidural insertion of trial electrode |
Percutaneous insertion of temporary spinal cord stimulator electrode into epidural space of spine (procedure) |
Epidurogram |
Fluoroscopy of epidural space with contrast |
Epilation of skin |
Epilation |
Epilepsy NOS |
A disease of the brain characterized by an enduring predisposition to generate epileptic seizures. |
Epilepsy NOS |
A disease of the brain characterized by an enduring predisposition to generate epileptic seizures. |
Epilepsy monitoring NOS |
Epilepsy monitoring |
Epilepsy monitoring NOS |
Epilepsy monitoring |
Epilepsy undetermined whether focal or generalized |
A disease of the brain characterized by an enduring predisposition to generate epileptic seizures. |
Epilepsy, not refractory |
A disease of the brain characterized by an enduring predisposition to generate epileptic seizures. |
Epileptic aura |
An epileptic seizure originating within networks limited to one hemisphere, in which the initial manifestation is non-motor (including autonomic, behavior arrest, cognitive, emotional, or sensory onsets), regardless of whether aware or with impaired awareness. |
Epileptic automatism |
Absence seizures present with a cessation of activity and impaired awareness associated with generalised spike and wave on EEG (electroencephalogram). An absence seizure is a generalised onset seizure and therefore, it originates at some point within, and rapidly engages, bilaterally distributed networks. |
Epileptic seizure witnessed by provider of history other than subject |
Epileptic seizure witnessed by history provider (situation) |
Epimerase |
Epimerase |
Epinephrine 0.5% eye drops |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
Epinephrine 0.5mg/mL injection solution |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL solution for injection |
Epinephrine 1.0% solution |
Adrenaline only product |
Epinephrine 1:10,000 100micrograms/1mL prefilled syringe |
Product containing only epinephrine in parenteral dose form (medicinal product form) |
Epinephrine 1:10,000 100micrograms/mL injection solution 3mL prefilled syringe |
Product containing only epinephrine in parenteral dose form (medicinal product form) |
Epinephrine 1:1000 1mg/mL topical solution |
Adrenaline 1 mg/mL nasal solution |
Epinephrine 1:1000 500micrograms/0.5mL injection |
Product containing only epinephrine in parenteral dose form (medicinal product form) |
Epinephrine 2.0% solution |
Adrenaline only product |
Epinephrine 500mcg/mL injection solution ampule |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL solution for injection |
Epinephrine 5mcg/lidocaine hydrochloride 15mg injection solution vial |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
Epinephrine 5mcg/prilocaine hydrochloride 40mg injection solution vial |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
Epinephrine acid tartrate 0.01% conventional release eye drops |
Adrenaline only product in ocular dose form |
Epinephrine acid tartrate 0.01% preservative-free eye drops |
Adrenaline only product in ocular dose form |
Epinephrine acid tartrate 0.1% conventional release eye drops |
Adrenaline only product in ocular dose form |
Epinephrine acid tartrate 0.1% preservative-free eye drops |
Adrenaline only product in ocular dose form |
Epinephrine bitartrate + pilocarpine hydrochloride 1%/1%wv solution |
Product containing only epinephrine and pilocarpine (medicinal product) |
Epinephrine bitartrate + pilocarpine hydrochloride 1%/2%wv solution |
Product containing only epinephrine and pilocarpine (medicinal product) |
Epinephrine bitartrate + pilocarpine hydrochloride 1%/4%wv solution |
Product containing only epinephrine and pilocarpine (medicinal product) |
Epinephrine bitartrate + pilocarpine hydrochloride 1%/6%wv solution |
Product containing only epinephrine and pilocarpine (medicinal product) |
Epinephrine bitartrate 5mcg/lidocaine hydrochloride 10mg injection solution vial |
Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form) |
Epinephrine hydrochloride 1% solution |
Adrenaline only product |
Epinephrine hydrochloride 1.9mg dental pellet |
Adrenaline only product in dental dose form |
Epinephrine hydrochloride 2% solution |
Adrenaline only product |
Epineural neurolysis |
Destruction - action |
Epiphyseal cartilage |
Structure of epiphyseal plate (body structure) |
Epiphysiolysis |
Epiphysiodesis |
Epirubicin hydrochloride 200mg/100mL solution |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Epirubicin hydrochloride 2mg/mL infusion solution 100mL vial |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Epirubicin hydrochloride 2mg/mL injection solution 100mL vial |
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Episcleritis periodica fugax |
Episcleritis |
Episcleritis periodica fugax |
Episcleritis |
Episiotomy wound |
Episiotomy wound |
Episodic drug abuse |
Episodic harmful pattern of substance use |
Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage I |
American Joint Committee on Cancer stage I (qualifier value) |